22 research outputs found
Eps8 Regulates Axonal Filopodia in Hippocampal Neurons in Response to Brain-Derived Neurotrophic Factor (BDNF)
A novel signaling cascade controlling actin polymerization in response to extracellular signals regulates filopodia formation and likely also neuronal synapse formation
Eps8 regulates axonal filopodia in hippocampal neurons in response to BDNF
The regulation of filopodia plays a crucial role during neuronal development and
synaptogenesis. Axonal filopodia, which are known to originate presynaptic
specializations, are regulated in response to neurotrophic factors. The structural
components of filopodia are actin filaments, whose dynamics and organization are
controlled by ensembles of actin binding proteins. How neurotrophic factors regulate
these latter proteins remains, however, poorly defined.
Here, using a combination of mouse genetic, biochemical and cell biological assays,
we show that genetic removal of Eps8, an actin-binding and regulatory protein
enriched in the growth cones and developing processes of neurons, significantly
augments the number and density of VASP-dependent axonal filopodia. The
reintroduction of Eps8 WT, but not an Eps8 capping-defective mutant into primary
hippocampal neurons restored axonal filopdia to wild type levels. We further show
that the actin barbed end capping activity of Eps8 is inhibited by BDNF treatment
through MAPK-dependent phosphorylation of Eps8 residues S624 and T628.
Additionally, an Eps8 mutant, impaired in the MAPK target sites (S624A/T628A),
displays increased association to actin-rich structures, is resistant to BDNF-mediated
release from microfilaments, and inhibits BDNF-induced filopodia. The opposite is
observed for a phosphomimetic Eps8 (S624E/T628E) mutant.
Thus, collectively, our data identify Eps8 as a critical capping protein in the
regulation of axonal filopodia and delineate a molecular pathway by which BDNF,
through MAPK-dependent phosphorylation of Eps8, stimulates axonal filopodia
formation, a process with crucial impacts on neuronal development and synapse
formation
The insulin receptor substrate of 53 kDa (IRSp53) limits hippocampal synaptic plasticity
IRSp53 is an essential intermediate between the activation of Rac and Cdc42 GTPases and the formation of cellular protrusions; it affects cell shape by coupling membrane-deforming activity with the actin cytoskeleton. IRSp53 is highly expressed in neurons where it is also an abundant component of the postsynaptic density (PSD). Here we analyze the physiological function of this protein in the mouse brain by generating IRSp53-deficient mice. Neurons in the hippocampus of young and adult knock-out (KO) mice do not exhibit morphological abnormalities in vivo. Conversely, primary cultured neurons derived from IRSp53 KO mice display retarded dendritic development in vitro. On a molecular level, Eps8 cooperates with IRSp53 to enhance actin bundling and interacts with IRSp53 in developing neurons. However, postsynaptic Shank proteins which are expressed at high levels in mature neurons compete with Eps8 to block actin bundling. In electrophysiological experiments the removal of IRSp53 increases synaptic plasticity as measured by augmented long term potentiation and paired-pulse facilitation. A primarily postsynaptic role of IRSp53 is underscored by the decreased size of the PSDs, which display increased levels of N-methyl-D-aspartate receptor subunits in IRSp53 KO animals. Our data suggest that the incorporation of IRSp53 into the PSD enables the protein to limit the number of postsynaptic glutamate receptors and thereby affect synaptic plasticity rather than dendritic morphology. Consistent with altered synaptic plasticity, IRSp53-deficient mice exhibit cognitive deficits in the contextual fear-conditioning paradigm